← All trials
NCT04461535
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2020
- Primary completion
- Jun 30, 2022
- Completion date
- Dec 31, 2023
- First posted
- Jul 8, 2020
- Last posted
- Jul 13, 2020
- Enrollment
- 140
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Chongqing Medical UniversityLead sponsor
- Chongqing Medical UniversityReponsible party - principal investigator
- the Chongqing Primary Aldosteronism Study (CONPASS) GroupStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.